Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Army
QuintilesIMS
Federal Trade Commission
Accenture
Cantor Fitzgerald

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 8,036,835

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,036,835
Title:Probe design methods and microarrays for comparative genomic hybridization and location analysis
Abstract: Methods and systems for identifying and selecting nucleic acid probes for detecting a target with a nucleic acid probe array or comparative genome hybridization microarray, comprising selecting a plurality of potential target sequences, generating a plurality of candidate probes from the target sequences, filtering the plurality of candidate probes by analyzing candidate probes for selected probe properties in silico. Microarrays comprising probes selected by the methods of the invention are particularly useful for comparative genome hybridization and location analysis.
Inventor(s): Sampas; Nicholas M. (San Francisco, CA), Curry; Bo (Redwood City, CA), Tsang; Peter (San Francisco, CA), Lipson; Doron (Tel-Aviv, IL), Yakhini; Zohar H. (Ramat Hasharon, IL)
Assignee: Agilent Technologies, Inc. (Santa Clara, CA)
Application Number:12/797,521
Patent Claims:see list of patent claims

Details for Patent 8,036,835

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Agilent Technologies, Inc. (Santa Clara, CA) 2037-11-08 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Agilent Technologies, Inc. (Santa Clara, CA) 2037-11-08 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Agilent Technologies, Inc. (Santa Clara, CA) 2037-11-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Covington
Chinese Patent Office
Baxter
Argus Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.